Patent · US Active

Chimeric peptide antagonist for GPCR135 or GPCR142

US8299028B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Chester Kuei · Anaheim, US
Changlu Liu · San Diego, US
Cindy M. Pudiak · Binghamton, US
Jonathan Edward Shelton · San Marcos, US
Steven W. Sutton · Carlsbad, US

Key dates

Filing date	Jan 23, 2008
Grant date	Oct 30, 2012
Priority date	—
Expiry date	Jul 21, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/50
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The chimeric polypeptide R3(BΔ23-27)R/I5 is described, which is a high-affinity antagonist for GPCR1 35 and GPCR1 42 over LGR7.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.